Neuroscience of Psychedelics
portes grátis
Neuroscience of Psychedelics
The Pharmacology of What Makes Us Human
Bouso, Jose Carlos; Ona, Genis
Inner Traditions Bear and Company
11/2024
264
Mole
9798888500040
15 a 20 dias
Descrição não disponível.
Foreword by Jose Carlos Bouso, Ph.D.
Preface
1 Brief Introduction to Pharmacology
Etymological Origins
Main Pharmacological Concepts
Nervous System * Neurons, Synapses,
and Action Potentials * Pharmacokinetics and
Pharmacodynamics * Neurotransmitters * Receptors *
Modifying Receptor Function
Why Psychedelic Pharmacology?
Pharmacology and Complexity
References for Further Study
2 Pharmacological Classification of the Main
Psychedelic Drugs: Structures and Major Groups
Simple Tryptamines, including Psilocybin
and DMT
Ergolamines, including LSD
Phenethylamines, including Mescaline and MDMA
NMDA Receptor Antagonists, including Ketamine
New Tryptamines
Atypical Psychedelics
Tabernanthe iboga * Salvia divinorum *
Datura stramonium
References for Further Study
3 Biological Targets of Psychedelic Drugs
Simple Tryptamine Targets
Psilocybin * DMT and Ayahuasca
Ergolamine Targets
LSD * LSA
Phenethylamine Targets
Mescaline * MDMA
Targets of NMDA Receptor Antagonists,
including Ketamine
Targets of New Tryptamines
Targets of Atypical Psychedelics
Ibogaine/Noribogaine * Salvinorin-A *
Datura stramonium
References for Further Study
4 Characteristic Aspects of Psychedelic Pharmacology
PHARMACOKINETICS
Initial Phases of the Processing of Psychedelics
Release * Absorption * Distribution
Metabolism
Metabolism and Aging *
Main Centers and Enzymes Responsible for Metabolism
Relevant Aspects in the Metabolism
of Psychedelic Drugs
Psilocybin * DMT/Ayahuasca * LSD * MDMA * Mescaline *
Ketamine * Ibogaine/Noribogaine * Salvinorin-A *
Tropane Alkaloids
Elimination
PHARMACODYNAMICS
Therapeutic Effects of Psychedelics
Antidepressant, Anti-inflammatory, and Neuroprotective
Effects * Therapeutic Effects of Atypical Psychedelics *
Increased Neuroplasticity * Neurological Evidence of
Psychedelics' Therapeutic Effects * Hormonal Effects *
Psychological Effects
Microdosing Psychedelics as an Emerging Trend
Adverse Effects in the Therapeutic Use of Psychedelics
Toxicity * Studying the Safety of Psychedelics * Health Risks
When Using Psychedelic Drugs Therapeutically
Psychoactive Effects of Psychedelics
Data on Psychedelics' Psychoactive Effects
Tolerance
References for Further Study
5 Harm Reduction in Your Use of Psychedelic Drugs
Take Care of Yourself * Check What You Bought *
Don't Get Creative with Routes of Administration *
Keep Hydrated * Don't Mix * Be Patient
6 A Look into the Future: Promises and Challenges
Marketing of Psychedelic Therapies
The Role of Traditional Knowledge
To Trip or Not to Trip
Appendix I: The Legal Status of Psychedelic Drugs
around the World
Appendix II: Glossary
Index
Preface
1 Brief Introduction to Pharmacology
Etymological Origins
Main Pharmacological Concepts
Nervous System * Neurons, Synapses,
and Action Potentials * Pharmacokinetics and
Pharmacodynamics * Neurotransmitters * Receptors *
Modifying Receptor Function
Why Psychedelic Pharmacology?
Pharmacology and Complexity
References for Further Study
2 Pharmacological Classification of the Main
Psychedelic Drugs: Structures and Major Groups
Simple Tryptamines, including Psilocybin
and DMT
Ergolamines, including LSD
Phenethylamines, including Mescaline and MDMA
NMDA Receptor Antagonists, including Ketamine
New Tryptamines
Atypical Psychedelics
Tabernanthe iboga * Salvia divinorum *
Datura stramonium
References for Further Study
3 Biological Targets of Psychedelic Drugs
Simple Tryptamine Targets
Psilocybin * DMT and Ayahuasca
Ergolamine Targets
LSD * LSA
Phenethylamine Targets
Mescaline * MDMA
Targets of NMDA Receptor Antagonists,
including Ketamine
Targets of New Tryptamines
Targets of Atypical Psychedelics
Ibogaine/Noribogaine * Salvinorin-A *
Datura stramonium
References for Further Study
4 Characteristic Aspects of Psychedelic Pharmacology
PHARMACOKINETICS
Initial Phases of the Processing of Psychedelics
Release * Absorption * Distribution
Metabolism
Metabolism and Aging *
Main Centers and Enzymes Responsible for Metabolism
Relevant Aspects in the Metabolism
of Psychedelic Drugs
Psilocybin * DMT/Ayahuasca * LSD * MDMA * Mescaline *
Ketamine * Ibogaine/Noribogaine * Salvinorin-A *
Tropane Alkaloids
Elimination
PHARMACODYNAMICS
Therapeutic Effects of Psychedelics
Antidepressant, Anti-inflammatory, and Neuroprotective
Effects * Therapeutic Effects of Atypical Psychedelics *
Increased Neuroplasticity * Neurological Evidence of
Psychedelics' Therapeutic Effects * Hormonal Effects *
Psychological Effects
Microdosing Psychedelics as an Emerging Trend
Adverse Effects in the Therapeutic Use of Psychedelics
Toxicity * Studying the Safety of Psychedelics * Health Risks
When Using Psychedelic Drugs Therapeutically
Psychoactive Effects of Psychedelics
Data on Psychedelics' Psychoactive Effects
Tolerance
References for Further Study
5 Harm Reduction in Your Use of Psychedelic Drugs
Take Care of Yourself * Check What You Bought *
Don't Get Creative with Routes of Administration *
Keep Hydrated * Don't Mix * Be Patient
6 A Look into the Future: Promises and Challenges
Marketing of Psychedelic Therapies
The Role of Traditional Knowledge
To Trip or Not to Trip
Appendix I: The Legal Status of Psychedelic Drugs
around the World
Appendix II: Glossary
Index
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
NEUROSCIENCE OF PSYCHEDELICS;PHARMACOLOGY AND HUMANITY;GENIS ONA;JOSE CARLOS BOUSO;LSD RESEARCH;DMT STUDIES;PSILOCYBIN THERAPY;AYAHUASCA EFFECTS;MESCALINE;KETAMINE TREATMENTS;IBOGAINE RESEARCH;SALVIA DIVINORUM;MDMA THERAPEUTIC USE;VISIONARY SUBSTANCES;BRAIN AND PSYCHEDELICS;PSYCHEDELIC SCIENCE;HARM REDUCTION
Foreword by Jose Carlos Bouso, Ph.D.
Preface
1 Brief Introduction to Pharmacology
Etymological Origins
Main Pharmacological Concepts
Nervous System * Neurons, Synapses,
and Action Potentials * Pharmacokinetics and
Pharmacodynamics * Neurotransmitters * Receptors *
Modifying Receptor Function
Why Psychedelic Pharmacology?
Pharmacology and Complexity
References for Further Study
2 Pharmacological Classification of the Main
Psychedelic Drugs: Structures and Major Groups
Simple Tryptamines, including Psilocybin
and DMT
Ergolamines, including LSD
Phenethylamines, including Mescaline and MDMA
NMDA Receptor Antagonists, including Ketamine
New Tryptamines
Atypical Psychedelics
Tabernanthe iboga * Salvia divinorum *
Datura stramonium
References for Further Study
3 Biological Targets of Psychedelic Drugs
Simple Tryptamine Targets
Psilocybin * DMT and Ayahuasca
Ergolamine Targets
LSD * LSA
Phenethylamine Targets
Mescaline * MDMA
Targets of NMDA Receptor Antagonists,
including Ketamine
Targets of New Tryptamines
Targets of Atypical Psychedelics
Ibogaine/Noribogaine * Salvinorin-A *
Datura stramonium
References for Further Study
4 Characteristic Aspects of Psychedelic Pharmacology
PHARMACOKINETICS
Initial Phases of the Processing of Psychedelics
Release * Absorption * Distribution
Metabolism
Metabolism and Aging *
Main Centers and Enzymes Responsible for Metabolism
Relevant Aspects in the Metabolism
of Psychedelic Drugs
Psilocybin * DMT/Ayahuasca * LSD * MDMA * Mescaline *
Ketamine * Ibogaine/Noribogaine * Salvinorin-A *
Tropane Alkaloids
Elimination
PHARMACODYNAMICS
Therapeutic Effects of Psychedelics
Antidepressant, Anti-inflammatory, and Neuroprotective
Effects * Therapeutic Effects of Atypical Psychedelics *
Increased Neuroplasticity * Neurological Evidence of
Psychedelics' Therapeutic Effects * Hormonal Effects *
Psychological Effects
Microdosing Psychedelics as an Emerging Trend
Adverse Effects in the Therapeutic Use of Psychedelics
Toxicity * Studying the Safety of Psychedelics * Health Risks
When Using Psychedelic Drugs Therapeutically
Psychoactive Effects of Psychedelics
Data on Psychedelics' Psychoactive Effects
Tolerance
References for Further Study
5 Harm Reduction in Your Use of Psychedelic Drugs
Take Care of Yourself * Check What You Bought *
Don't Get Creative with Routes of Administration *
Keep Hydrated * Don't Mix * Be Patient
6 A Look into the Future: Promises and Challenges
Marketing of Psychedelic Therapies
The Role of Traditional Knowledge
To Trip or Not to Trip
Appendix I: The Legal Status of Psychedelic Drugs
around the World
Appendix II: Glossary
Index
Preface
1 Brief Introduction to Pharmacology
Etymological Origins
Main Pharmacological Concepts
Nervous System * Neurons, Synapses,
and Action Potentials * Pharmacokinetics and
Pharmacodynamics * Neurotransmitters * Receptors *
Modifying Receptor Function
Why Psychedelic Pharmacology?
Pharmacology and Complexity
References for Further Study
2 Pharmacological Classification of the Main
Psychedelic Drugs: Structures and Major Groups
Simple Tryptamines, including Psilocybin
and DMT
Ergolamines, including LSD
Phenethylamines, including Mescaline and MDMA
NMDA Receptor Antagonists, including Ketamine
New Tryptamines
Atypical Psychedelics
Tabernanthe iboga * Salvia divinorum *
Datura stramonium
References for Further Study
3 Biological Targets of Psychedelic Drugs
Simple Tryptamine Targets
Psilocybin * DMT and Ayahuasca
Ergolamine Targets
LSD * LSA
Phenethylamine Targets
Mescaline * MDMA
Targets of NMDA Receptor Antagonists,
including Ketamine
Targets of New Tryptamines
Targets of Atypical Psychedelics
Ibogaine/Noribogaine * Salvinorin-A *
Datura stramonium
References for Further Study
4 Characteristic Aspects of Psychedelic Pharmacology
PHARMACOKINETICS
Initial Phases of the Processing of Psychedelics
Release * Absorption * Distribution
Metabolism
Metabolism and Aging *
Main Centers and Enzymes Responsible for Metabolism
Relevant Aspects in the Metabolism
of Psychedelic Drugs
Psilocybin * DMT/Ayahuasca * LSD * MDMA * Mescaline *
Ketamine * Ibogaine/Noribogaine * Salvinorin-A *
Tropane Alkaloids
Elimination
PHARMACODYNAMICS
Therapeutic Effects of Psychedelics
Antidepressant, Anti-inflammatory, and Neuroprotective
Effects * Therapeutic Effects of Atypical Psychedelics *
Increased Neuroplasticity * Neurological Evidence of
Psychedelics' Therapeutic Effects * Hormonal Effects *
Psychological Effects
Microdosing Psychedelics as an Emerging Trend
Adverse Effects in the Therapeutic Use of Psychedelics
Toxicity * Studying the Safety of Psychedelics * Health Risks
When Using Psychedelic Drugs Therapeutically
Psychoactive Effects of Psychedelics
Data on Psychedelics' Psychoactive Effects
Tolerance
References for Further Study
5 Harm Reduction in Your Use of Psychedelic Drugs
Take Care of Yourself * Check What You Bought *
Don't Get Creative with Routes of Administration *
Keep Hydrated * Don't Mix * Be Patient
6 A Look into the Future: Promises and Challenges
Marketing of Psychedelic Therapies
The Role of Traditional Knowledge
To Trip or Not to Trip
Appendix I: The Legal Status of Psychedelic Drugs
around the World
Appendix II: Glossary
Index
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
NEUROSCIENCE OF PSYCHEDELICS;PHARMACOLOGY AND HUMANITY;GENIS ONA;JOSE CARLOS BOUSO;LSD RESEARCH;DMT STUDIES;PSILOCYBIN THERAPY;AYAHUASCA EFFECTS;MESCALINE;KETAMINE TREATMENTS;IBOGAINE RESEARCH;SALVIA DIVINORUM;MDMA THERAPEUTIC USE;VISIONARY SUBSTANCES;BRAIN AND PSYCHEDELICS;PSYCHEDELIC SCIENCE;HARM REDUCTION
